UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008367
Receipt number R000009823
Scientific Title Establishment of organ specific insulin resistance indices in lifestyle-related diseases
Date of disclosure of the study information 2012/08/01
Last modified on 2022/01/12 16:12:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of organ specific insulin resistance indices in lifestyle-related diseases

Acronym

Euglycemic hyperinsulinemic clamp with stable isotope tracer infusion

Scientific Title

Establishment of organ specific insulin resistance indices in lifestyle-related diseases

Scientific Title:Acronym

Euglycemic hyperinsulinemic clamp with stable isotope tracer infusion

Region

Japan


Condition

Condition

Lifestyle-related diseases

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine organ specific insulin resistance in patient with lifestyle-related diseases and to establish simple insulin resistance indices.

Basic objectives2

Others

Basic objectives -Others

Validity

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Hepatic and peripheral tissue insulin resistance (hepatic glucose production and insulin-stimulated glucose disposal)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Lifestyle-related diseases

Key exclusion criteria

1)Uncontrolled diabetes (HbA1c >10%)
2)Uncontrolled hypertension (systolic blood pressure >180mmHg or diastolic blood pressure >110mmHg)
3)Pregnant or lactating women

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Toshinari
Middle name
Last name TAKAMURA

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Endocrinology and Metabolism

Zip code

920-8640

Address

13-1 Takara-machi, Kanazawa, Ishikawa, Japan

TEL

076-265-2234

Email

ttakamura@m-kanazawa.jp


Public contact

Name of contact person

1st name Toshinari
Middle name
Last name Takamura

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Endocrinology and Metabolism

Zip code

920-8640

Address

13-1 Takara-machi, Kanazawa, Ishikawa, Japan

TEL

076-265-2234

Homepage URL


Email

ttakamura@m-kanazawa.jp


Sponsor or person

Institute

Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Innovative clinical research center

Address

13-1 takaramachi kanazawa Ishikawa

Tel

(076)265-2100

Email

t-isomu@adm.kanazawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

In progress

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 04 Month 09 Day

Date of IRB

2015 Year 02 Month 24 Day

Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No adverse event


Management information

Registered date

2012 Year 07 Month 06 Day

Last modified on

2022 Year 01 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009823


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name